Walden Group Healthcare M&A Blog

  • Hologic Acquires Acessa Health for $80M

    Hologic (Nasdaq: HOLX), a $3.4b developer of diagnostics, imaging systems, surgical products, and light-based aesthetic and medical treatment platforms for women is buying Acessa Health, the developer of the Acessa ProVu system, a laparoscopic device combining radiofrequency ablation and advanced intra-abdominal ultrasound to treat benign uterine...
    Read More
  • Thermo Fisher Terminates $12.4b Planned Purchase of Qiagen

    After Thermo Fisher originally announced a $11.5b takeover bid for Netherlands-based Qiagen in March, an amended $12.4b acquisition proposal has since lapsed in accordance with its terms, terminating the deal.    A campaign against the deal spear-headed by institutional investor Davidson Kempner Capital which owned a 3% stake in Qiagen as of...
    Read More
  • Medtronic To Buy Companion Medical

    Ireland-based Medtronic plc, a $28.9b maker of cardiac, vascular, diabetes, restorative therapy and minimally invasive devices. is buying Companion Medical, a developer of a “smart” insulin pens and accompanying mobile apps for personalized diabetes management.  The deal adds an FDA-cleared, first-of-its kind "smart” insulin device, InPen,...
    Read More
  • Teladoc Health to Buy Livongo in $18.5b Mega-Deal

    Teladoc (NYSE: TDOC), a $553.3m telemedicine provider, is buying Livongo (Nasdaq: LVGO), a $170.2m digital health and virtual diabetes coaching company, in an $18.5b merger, to create a company with a combined $1.3b in revenue in 2020, up 85% YOY.  This is the largest digital health deal in history, ringing in at a purchase price for Livongo at...
    Read More
  • Creo Medical Acquires Albyn Medical for $29.3m

    Creo Medical, a UK-based developer of endoscopic microwave and radiofrequency ablation technologies, is acquiring Albyn Medical, a Spain-based manufacturer of branded and third-party gastroenterology, urology and endoscopy products including biopsy forceps, snares, catheters, tubes and valves. The acquisition expands Creo’s GI product suite and...
    Read More